Forum: Clinical Trials
12-11-2016, 01:49 AM
|
Replies: 5
Views: 11,879
Re: Update to Tucatinib/ONT380 phase 2 trial
Me too, Pam (following with interest). There was a lot of HER2 at SABCS this year. Including, it seemed to me, more focus on the subgroups within (triple positive, and others that sort out...
|
Forum: Clinical Trials
12-08-2016, 12:53 PM
|
Replies: 5
Views: 11,879
Update to Tucatinib/ONT380 phase 2 trial
SAN ANTONIO, Texas, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Cascadian Therapeutics, Inc. (NASDAQ:CASC), a clinical-stage biopharmaceutical company, today announced that following a recent meeting with the...
|